Patents Examined by Shoba Kantamneni
  • (bis)urea and (bis)thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
    Patent number: 9708255
    Abstract: The invention provides for novel (bis)urea and (bis)thiourea compounds which are inhibitors of lysine-specific demethylase 1 (LSD1). Such compounds may be used to treat disorders, including cancer.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: July 18, 2017
    Inventors: Robert A. Casero, Patrick M. Woster
  • Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
    Patent number: 8575169
    Abstract: Compositions and methods for treatment of sexual dysfunctions by administering to a subject a pharmaceutical composition comprising a delta opioid receptor agonist in an amount effective to delay the onset of ejaculation in the subject during sexual stimulation.
    Type: Grant
    Filed: January 2, 2003
    Date of Patent: November 5, 2013
    Assignee: Versi Group, LLC
    Inventors: Kwen-Jen Chang, Klim King, Kestutis P. Biciunas, Robert W. McNutt, Jr., William Pendergast, Shyi-Tai Jan
  • Regulation of intracellular glucocorticoid concentrations
    Patent number: 7122531
    Abstract: This invention relates to the interconversion of inactive 11-keto steroids with their active 11B-hydroxy equivalents, to methods by which the conversion of the inactive to the active form may be controlled, and to useful therapeutic effects which may be obtained as a result of such control. More specifically, but not exclusively, the invention is concerned with interconversion between cortisone and cortisol in humans.
    Type: Grant
    Filed: February 22, 2002
    Date of Patent: October 17, 2006
    Assignee: The University of Edinburgh
    Inventors: Brian Robert Walker, Christopher Richard Watkin Edwards, Jonathan Robert Seckl